Daniel P. O'Day
Chairman and Chief Executive Officer, Gilead Sciences
In the news
CEO Daniel O'Day sells 15,000 Gilead shares at about $147.90 on October 1
Chairman and CEO Daniel O'Day sold 15,000 Gilead shares on October 1, 2026, in two blocks: 12,000 shares at about $147.72 and 3,000 at about $148.63.
Insiders
CEO Daniel O'Day sells 15,000 Gilead shares at about $148.64
Chairman and CEO Daniel O'Day sold 15,000 Gilead shares on September 1, 2026, in three blocks priced from $146.94 to $149.94, a weighted average of about $148.64.
Insiders
CEO Daniel O'Day sells 15,000 Gilead shares under a 10b5-1 plan
Chairman and CEO Daniel O'Day sold 15,000 Gilead shares on August 3, 2026, in three open-market blocks priced from about $129.17 to $131.47, a weighted average of about $130.31.
Insiders
Gilead Q1 2026 beats: product sales ex-Veklury up 8%, product guidance raised, EPS guidance cut to a loss
Gilead's first-quarter revenue rose 4% to $6.96 billion, and product sales excluding Veklury grew 8% to $6.8 billion.
Earnings
Gilead reports 2025 results and guides 2026 product sales to $29.6-30.0 billion
Gilead reported fourth-quarter and full-year 2025 results and set 2026 guidance.
Earnings